SCHEMBL29924775

SCHEMBL29924775

Fc1cc(Cl)ccc1C1COc2ccccc2O1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.44
ALDH1A1 P00352 4/20 0.44
TP53 P04637 2/20 0.44
HPGD P15428 2/20 0.44
HTT P42858 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
GPR55 Q9Y2T6 1/20 0.44
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
NPC1 O15118 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
LTA4H P09960 7/20 0.40
NISCH Q9Y2I1 2/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29424063 0.85 MAPT (0.46) MAPTALDH1A1TP53HPGDHTT
SCHEMBL29150127 0.83 HCRTR2 (0.39) MAPTHTTHTR2AHTR2CHTR2B
SCHEMBL23980935 0.82 CYP11B1 (0.39) HPGDHTR2AHTR2CHTR2BNPC1
SCHEMBL24186456 0.82 HTR2A (0.37) MAPTALDH1A1TP53HPGDHTT
SCHEMBL23980833 0.82 HTR2A (0.37) MAPTALDH1A1TP53HPGDHTT
SCHEMBL29924349 0.82 HTR2A (0.37) MAPTALDH1A1TP53HPGDHTT
SCHEMBL30275367 0.82 CYP11B1 (0.39) HPGDHTR2AHTR2CHTR2BNPC1
SCHEMBL24969521 0.82 MAPT (0.43) MAPTALDH1A1TP53HPGDHTT
SCHEMBL28949266 0.82 ADRA2A (0.52) HTR2AHTR2CHTR2BADRA2AADRA2B
SCHEMBL30217488 0.82 ADRA2A (0.52) HTR2AHTR2CHTR2BADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568664-A1 COMBINATION COMPRISING A THR-BETA AGONIST AND A GLP-1R AGONIST FOR USE IN TREATING A LIVER DISORDER OR A CARDIOMETABOLIC DISEASE Terns Pharmaceuticals, Inc. (US) 2025-06-18 EP disclosed
WO-2024211898-A1 COMBINATION COMPRISING A THRBETA AGONIST ANDA GLP-1R AGONIST FOR USE IN TREATING A LIVER DISORDER OR A CARDIOMETABOLIC DISEASE TERNS PHARMACEUTICALS, INC. (US) 2024-10-10 WO disclosed
WO-2022228490-A1 POLYCYCLIC DERIVATIVE MODULATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2022-11-03 WO disclosed